Assessment of the New Automated Vitrification System "GAVI" for Early Cleaved Embryos Cryopreservation
GAVI
1 other identifier
interventional
423
1 country
1
Brief Summary
The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies (ART) center of Toulouse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2018
CompletedFirst Submitted
Initial submission to the registry
March 15, 2018
CompletedFirst Posted
Study publicly available on registry
March 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2021
CompletedOctober 28, 2021
October 1, 2021
3 years
March 15, 2018
October 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implantation rate of frozen/thawed embryos
The number of implantation embryo with cardiac activity in reference technique and in vitrification technic
1 month
Secondary Outcomes (3)
Percentage of intact blastomeres after thawing
1 month
Implantation rate of transferred embryos.
1 month
Live birth rates
9 months after the implantation
Study Arms (2)
reference technique slow freezing
EXPERIMENTALIn reference technique slow freezing arm, embryon will be frozen with the conventional slow freezing procedure with the Freezal device apply a slow decreasing in temperature with moderate cryoprotector concentration
vitrification technique
EXPERIMENTALIn vitrification technique arm, embryon will be frozen with automated vitrification system
Interventions
Slow-freezing procedure is the reference technique, actually use at the Toulouse hospital, to cryopreserve embryos. Embryon are frozen with a slow freezing.
Vitrification is the new technique to freeze embryons. In this study, the GAVI system will be use for for embryos automatically vitrification
Eligibility Criteria
You may qualify if:
- Couple whose age is \> 18 years and who are included in a IVF procedure with the possibility to cryopreserve embryos according to criteria applied at the hospital of Toulouse
- Signed informed consent by both partners in a couple
- Affiliation to a social security scheme for both partners of the couple
You may not qualify if:
- Couples who does not meet current requirements described by the bioethics law for accession to the ART procedure
- One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
- Couple included in another interventional study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital university of Toulouse
Toulouse, 31059, France
Study Officials
- PRINCIPAL INVESTIGATOR
Roger Léandri, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2018
First Posted
March 27, 2018
Study Start
January 19, 2018
Primary Completion
February 3, 2021
Study Completion
February 3, 2021
Last Updated
October 28, 2021
Record last verified: 2021-10